Skip to main content

Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL Title Category Date Recent Activity
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-cardiac-congenital-malformations-following-armodafinil Risk of Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis Modular Programs
Risk of Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis
Modular Programs
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-mothers-mother-infant-linkage-table Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis Modular Programs
Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis
Modular Programs
https://www.sentinelinitiative.org/methods-data-tools/methods/using-unsupervised-learning-harmonize-data-across-data-systems Using Unsupervised Learning to Harmonize Data Across Data Systems Methods, Data, & Tools
Using Unsupervised Learning to Harmonize Data Across Data Systems
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/brand-and-generic-tacrolimus-use-following-kidney-heart-and Brand and Generic Tacrolimus Use following Kidney, Heart, and Liver Transplants: A Descriptive Analysis Modular Programs
Brand and Generic Tacrolimus Use following Kidney, Heart, and Liver Transplants: A Descriptive Analysis
Modular Programs
https://www.sentinelinitiative.org/news-events/publications-presentations/prescription-medication-use-and-baseline-health-status-women Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network: The Sentinel Distributed Database Mother-Infant Linkage Table Publications and Presentations
Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network: The Sentinel Distributed Database Mother-Infant Linkage Table
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/methods/longitudinal-trends-incident-and-prevalent-use-long-acting-beta-2 Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis Methods, Data, & Tools
Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/publications-presentations/prescription-medication-use-and-baseline-health-status-0 Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network Publications and Presentations
Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/racial-differences-covid-19-outcomes-2020-2021 Racial Differences in COVID-19 Outcomes (2020-2021) Assessments
Racial Differences in COVID-19 Outcomes (2020-2021)
Assessments
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-and-hospitalized-depression-following Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis Analyses
Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-and-hospitalized-depression-0 Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis (A Follow-up to a Previous Analysis) Analyses
Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis (A Follow-up to a Previous Analysis)
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/n-nitrosodimethylamine-ndma-contaminated-and-non-ndma N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis Analyses
N‐nitrosodimethylamine (NDMA)‐Contaminated and Non‐NDMA‐Contaminated Valsartan Use: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-and-prevalence-n-nitrosodimethylamine-ndma-and-n Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis Analyses
Incidence and Prevalence of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Contaminated Valsartan Use: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/methods/augmenting-date-death-cause-death-ascertainment-sentinel Augmenting Date of Death & Cause of Death Ascertainment in Sentinel Methods, Data, & Tools
Augmenting Date of Death & Cause of Death Ascertainment in Sentinel
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/valganciclovir-use-children-congenital-cytomegalovirus Valganciclovir Use in Children with Congenital Cytomegalovirus Disease (cCMV) or Cytomegalovirus (CMV) Infection: A Descriptive Analysis Analyses
Valganciclovir Use in Children with Congenital Cytomegalovirus Disease (cCMV) or Cytomegalovirus (CMV) Infection: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/landscape-analysis-valganciclovir-treatment-congenital A Landscape Analysis of Valganciclovir Treatment for Congenital Cytomegalovirus Infection in the United States (US), 2008-2021 Publications and Presentations
A Landscape Analysis of Valganciclovir Treatment for Congenital Cytomegalovirus Infection in the United States (US), 2008-2021
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/thromboembolic-stroke-major-extracranial-bleeding-0 Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 or Older: An Inverse Probability of Treatment Weighting (IPTW) Analysis Analyses
Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use in Patients Aged 65 or Older: An Inverse Probability of Treatment Weighting (IPTW) Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterizing-pregnant-women-and-without-evidence-heart Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis Analyses
Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/tacrolimus-use-patients-following-liver-or-kidney Tacrolimus Use in Patients Following Liver or Kidney Transplants: A Descriptive Analysis Analyses
Tacrolimus Use in Patients Following Liver or Kidney Transplants: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/seizures-following-gadolinium-based-contrast-agents-exposure Seizures Following Gadolinium-Based Contrast Agents Exposure: A Self-Controlled Risk Interval Analysis Analyses
Seizures Following Gadolinium-Based Contrast Agents Exposure: A Self-Controlled Risk Interval Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-infants-mother-infant-linkage-table Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis Analyses
Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/impact-nitrosamine-contamination-recalls-angiotensin Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark Publications and Presentations
Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/use-valganciclovirganciclovir-vgcv-treatment-congenital Use of Valganciclovir/Ganciclovir [(v)GCV] for Treatment of Congenital Cytomegalovirus (cCMV) Infection in the United States: Evidence from the Sentinel Distributed Database, 2008-2020 Spotlight
Use of Valganciclovir/Ganciclovir [(v)GCV] for Treatment of Congenital Cytomegalovirus (cCMV) Infection in the United States: Evidence from the Sentinel Distributed Database, 2008-2020
Spotlight
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-infants-sentinel-distributed-database-mother Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table Publications and Presentations
Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/fractures-following-leuprolide-acetate-use-multiple-factor Fractures Following Leuprolide Acetate Use: A Multiple Factor Matched Analysis (A Follow-up to a Previous Analysis) Analyses
Fractures Following Leuprolide Acetate Use: A Multiple Factor Matched Analysis (A Follow-up to a Previous Analysis)
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-zarxio-use-signal Outcome Monitoring Following Zarxio Use: A Signal Identification Analysis Analyses
Outcome Monitoring Following Zarxio Use: A Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-ozempic-use-patients-type-2 Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis Analyses
Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/methods/inclusion-semi-structured-and-unstructured-electronic-health-record-ehr Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment Methods, Data, & Tools
Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/methods/development-and-evaluation-electronic-health-record-ehr-information Development and Evaluation of Electronic Health Record (EHR) Information Extraction Pipeline and Tree-Based Scan Statistic (TBSS) Methods for EHR-Based Signal Detection (DA2) Methods, Data, & Tools
Development and Evaluation of Electronic Health Record (EHR) Information Extraction Pipeline and Tree-Based Scan Statistic (TBSS) Methods for EHR-Based Signal Detection (DA2)
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/cardiovascular-outcomes-following-percutaneous Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: An Updated Descriptive Analysis Analyses
Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: An Updated Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-or-linked-infant Congenital Malformations Observed in the Mother’s or Linked Infant’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis Analyses
Congenital Malformations Observed in the Mother’s or Linked Infant’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-records-following Congenital Malformations Observed in the Mother’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis Analyses
Congenital Malformations Observed in the Mother’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-zarxio-use-updated-signal Outcome Monitoring Following Zarxio Use: An Updated Signal Identification Analysis Analyses
Outcome Monitoring Following Zarxio Use: An Updated Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/valsartan-losartan-and-irbesartan-use-usa-uk-canada-and Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study Publications and Presentations
Valsartan, Losartan and Irbesartan Use in the USA, UK, Canada and Denmark After the Nitrosamine Recalls: A Descriptive Cohort Study
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/angioedema-following-sacubitrilvalsartan-use-patients-heart Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis Analyses
Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/angioedema-following-sacubitrilvalsartan-use-patients-0 Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: An Updated Propensity Score Matched Analysis Analyses
Angioedema Following Sacubitril/Valsartan Use in Patients with Heart Failure: An Updated Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/assessment-sentinel-system-focus-active-risk-identification An Assessment of the Sentinel System: Focus on the Active Risk Identification and Analysis (ARIA) System Publications and Presentations
An Assessment of the Sentinel System: Focus on the Active Risk Identification and Analysis (ARIA) System
Publications and Presentations
https://www.sentinelinitiative.org/news-events/fda-safety-communications-labeling-changes/informed-original-fda-labeling-paxlovid Informed Original FDA Labeling: Paxlovid Boxed Warning on Drug Interactions Regulatory Impact
Informed Original FDA Labeling: Paxlovid Boxed Warning on Drug Interactions
Regulatory Impact
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/mortality-following-long-acting-injectable-antipsychotics Mortality Following Long-Acting Injectable Antipsychotics Use in Patients with Dementia: An Inverse Probability of Treatment Weighting Analysis Analyses
Mortality Following Long-Acting Injectable Antipsychotics Use in Patients with Dementia: An Inverse Probability of Treatment Weighting Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-erenumab-use-signal Outcome Monitoring Following Erenumab Use: A Signal Identification Analysis Analyses
Outcome Monitoring Following Erenumab Use: A Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/renal-cell-carcinoma-following-canagliflozin-use-patients Renal Cell Carcinoma Following Canagliflozin Use in Patients with Type 2 Diabetes: A Descriptive Analysis Analyses
Renal Cell Carcinoma Following Canagliflozin Use in Patients with Type 2 Diabetes: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-beta-blockers-pediatric-population-descriptive Utilization of Beta Blockers in the Pediatric Population: A Descriptive Analysis Analyses
Utilization of Beta Blockers in the Pediatric Population: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-beta-blockers-pediatric-population-updated Utilization of Beta Blockers in the Pediatric Population: An Updated Descriptive Analysis Analyses
Utilization of Beta Blockers in the Pediatric Population: An Updated Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/utilization-beta-blockers-among-pediatric-population-united Utilization of Beta-blockers Among the Pediatric Population in the United States: A Study in the FDA’s Sentinel System from 2008 to 2022 Publications and Presentations
Utilization of Beta-blockers Among the Pediatric Population in the United States: A Study in the FDA’s Sentinel System from 2008 to 2022
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-products-development-pregnancy-safety-study Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers with Live-Birth Deliveries: A Descriptive Analysis Analyses
Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers with Live-Birth Deliveries: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-products-development-pregnancy-safety-study-0 Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers Linked to Live-Birth Deliveries in the Mother-Infant Linkage Table: A Descriptive Analysis Analyses
Utilization of Products for the Development of the Pregnancy Safety Study Framework Among Mothers Linked to Live-Birth Deliveries in the Mother-Infant Linkage Table: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/preliminary-analysis-drug-utilization-data-inform Preliminary Analysis of Drug Utilization Data to Inform the Development of the Pregnancy Safety Study Framework Publications and Presentations
Preliminary Analysis of Drug Utilization Data to Inform the Development of the Pregnancy Safety Study Framework
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/covid-19-hospitalization-and-severe-covid-19-infection-0 COVID-19 Hospitalization and Severe COVID-19 Infection Following Proton Pump Inhibitor (PPI) Use in Patients with Gastroesophageal Reflux Disease (GERD): An Inverse Probability of Treatment Weighting Analysis Analyses
COVID-19 Hospitalization and Severe COVID-19 Infection Following Proton Pump Inhibitor (PPI) Use in Patients with Gastroesophageal Reflux Disease (GERD): An Inverse Probability of Treatment Weighting Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-non-cardiac-congenital-malformations-following Risk of Non-Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis Analyses
Risk of Non-Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/methods/strengthening-inferential-studies-us-fda-sentinel-initiative Strengthening Inferential Studies in the U.S. FDA Sentinel Initiative: A Methodological Demonstration Project Methods, Data, & Tools
Strengthening Inferential Studies in the U.S. FDA Sentinel Initiative: A Methodological Demonstration Project
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/methods/systematic-process-assessing-fitness-purpose-health-outcomes-computable A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping with Electronic Health Records Data Methods, Data, & Tools
A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping with Electronic Health Records Data
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-pegylated-liposomal-doxorubicin Counts and Characteristics of Pegylated Liposomal Doxorubicin and Non-Liposomal Doxorubicin Users: A Descriptive Analysis Analyses
Counts and Characteristics of Pegylated Liposomal Doxorubicin and Non-Liposomal Doxorubicin Users: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/lipiodol-ethiodized-oil-and-other-non-oil-based-iodine Lipiodol (Ethiodized Oil) and Other Non-Oil Based Iodine Imaging Agent Utilization Patterns: A Descriptive Analysis Analyses
Lipiodol (Ethiodized Oil) and Other Non-Oil Based Iodine Imaging Agent Utilization Patterns: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/covid-19-chart-validation-covid-19-severity-algorithm COVID-19 Chart Validation of COVID-19 Severity Algorithm Methods, Data, & Tools
COVID-19 Chart Validation of COVID-19 Severity Algorithm
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-baloxavir-use-signal Outcome Monitoring Following Baloxavir Use: A Signal Identification Analysis Analyses
Outcome Monitoring Following Baloxavir Use: A Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/process-guide-inferential-studies-using-healthcare-data Process Guide for Inferential Studies Using Healthcare Data from Routine Clinical Practice to Evaluate Causal Effects of Drugs (PRINCIPLED): Considerations from the FDA Sentinel Innovation Center Publications and Presentations
Process Guide for Inferential Studies Using Healthcare Data from Routine Clinical Practice to Evaluate Causal Effects of Drugs (PRINCIPLED): Considerations from the FDA Sentinel Innovation Center
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/sentinel-common-data-model Sentinel Common Data Model Methods, Data, & Tools
Sentinel Common Data Model
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-dupilumab-use-signal Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis Analyses
Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/sodium-glucose-cotransporter-2-sglt2-inhibitor-use-patients Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use in Patients with Diabetes Mellitus: A Descriptive Analysis Analyses
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor Use in Patients with Diabetes Mellitus: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-following-montelukast-use-patients Intentional Self-Harm Following Montelukast Use in Patients with Asthma: An Updated Analysis Using ICD-10-CM Coding Analyses
Intentional Self-Harm Following Montelukast Use in Patients with Asthma: An Updated Analysis Using ICD-10-CM Coding
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/targeted-learning-undersmoothed-lasso-propensity-score-model Targeted Learning with an Undersmoothed Lasso Propensity Score Model for Large-Scale Covariate Adjustment in Healthcare Database Studies Publications and Presentations
Targeted Learning with an Undersmoothed Lasso Propensity Score Model for Large-Scale Covariate Adjustment in Healthcare Database Studies
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-products-over-time-development-pregnancy-safety Utilization of Products Over Time for the Development of the Pregnancy Safety Study Framework Among Mothers with Live-Birth Deliveries: A Descriptive Analysis Analyses
Utilization of Products Over Time for the Development of the Pregnancy Safety Study Framework Among Mothers with Live-Birth Deliveries: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/hydrochlorothiazide-use-following-labeling-update-include-0 Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Interrupted Time Series Analysis Analyses
Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Interrupted Time Series Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/interstitial-lung-disease-ild-patients-inflammatory-bowel Interstitial Lung Disease (ILD) in Patients with Inflammatory Bowel Disease (IBD) and Following Vedolizumab or Natalizumab Initiation: A Descriptive Analysis Analyses
Interstitial Lung Disease (ILD) in Patients with Inflammatory Bowel Disease (IBD) and Following Vedolizumab or Natalizumab Initiation: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/interstitial-lung-disease-ild-rates-patients-inflammatory Interstitial Lung Disease (ILD) Rates in Patients with Inflammatory Bowel Disease (IBD) and Following IBD Advanced Therapy: A Descriptive Analysis Analyses
Interstitial Lung Disease (ILD) Rates in Patients with Inflammatory Bowel Disease (IBD) and Following IBD Advanced Therapy: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/general-framework-developing-computable-clinical-phenotype A General Framework for Developing Computable Clinical Phenotype Algorithms Publications and Presentations
A General Framework for Developing Computable Clinical Phenotype Algorithms
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/finding-uncoded-anaphylaxis-electronic-health-records Finding Uncoded Anaphylaxis in Electronic Health Records to Estimate the Sensitivity of ICD10 Codes Publications and Presentations
Finding Uncoded Anaphylaxis in Electronic Health Records to Estimate the Sensitivity of ICD10 Codes
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-beta-blockers-pediatric-population-follow Utilization of Beta Blockers in the Pediatric Population: A Follow Up Updated Descriptive Analysis Analyses
Utilization of Beta Blockers in the Pediatric Population: A Follow Up Updated Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/principled-approach-characterize-and-analyze-partially A Principled Approach to Characterize and Analyze Partially Observed Confounder Data from Electronic Health Records Publications and Presentations
A Principled Approach to Characterize and Analyze Partially Observed Confounder Data from Electronic Health Records
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/data-quality-review-and-characterization-programs Data Quality Review and Characterization Programs Methods, Data, & Tools
Data Quality Review and Characterization Programs
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/sentinel-common-components-sas-program-package Sentinel Common Components SAS® Program Package Common Data Model
Sentinel Common Components SAS® Program Package
Common Data Model
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/serious-infection-following-ustekinumab-use-patients-crohn-0 Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis Analyses
Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-following-glucagon-peptide-1-receptor Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis Analyses
Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/intentional-self-harm-following-glucagon-peptide-1-0 Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Obesity: A Descriptive Analysis Analyses
Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Obesity: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/cannabis Cannabis & Substance Use Disorder and Poisoning Studies
Cannabis & Substance Use Disorder and Poisoning
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-adverse-neonatal-health-outcomes-among-pregnant Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis Analyses
Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/pediatric-patients-0 Pediatric Patients & Characterization Studies
Pediatric Patients & Characterization
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-adverse-maternal-health-outcomes-among-pregnant Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis Analyses
Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-and-drug-utilization-pregnant-patients-covid Characteristics and Drug Utilization in Pregnant Patients With COVID-19: A Propensity Score Matched Analysis Analyses
Characteristics and Drug Utilization in Pregnant Patients With COVID-19: A Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-infants-mother-infant-linkage-table-0 Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: An Updated Descriptive Analysis Analyses
Characterization of Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: An Updated Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/thromboembolic-stroke-intracranial-hemorrhage-0 Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis Analyses
Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding Following Apixaban, Dabigatran, and Rivaroxaban Use in Patients Aged 64 Years and Younger with Atrial Fibrillation: An Inverse Probability of Treatment Weighting Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-healthcare-utilization-during-covid-19-pandemic Trends in Healthcare Utilization During the COVID-19 Pandemic: A Propensity Score Matched and Stratified Analysis in Merative™ MarketScan® Research Databases Analyses
Trends in Healthcare Utilization During the COVID-19 Pandemic: A Propensity Score Matched and Stratified Analysis in Merative™ MarketScan® Research Databases
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-healthcare-utilization-during-covid-19-pandemic-0 Trends in Healthcare Utilization During the COVID-19 Pandemic: A Propensity Score Matched and Stratified Analysis in the Sentinel Distributed Database Analyses
Trends in Healthcare Utilization During the COVID-19 Pandemic: A Propensity Score Matched and Stratified Analysis in the Sentinel Distributed Database
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/advancing-drug-safety-signal-management-through-multimodal Advancing Drug Safety Signal Management through Multimodal Approaches in Networking Publications and Presentations
Advancing Drug Safety Signal Management through Multimodal Approaches in Networking
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/analysis-medicinal-product-utilization-data-fda-sentinel Analysis of Medicinal Product Utilization Data in the FDA Sentinel System to Inform the Development of a Pregnancy Safety Study Framework  Publications and Presentations
Analysis of Medicinal Product Utilization Data in the FDA Sentinel System to Inform the Development of a Pregnancy Safety Study Framework 
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/beta-blocker-associated-hypoglycemia-pediatric-patients Beta-Blocker-Associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database Publications and Presentations
Beta-Blocker-Associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-infants-sentinel-distributed-database-0 Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table Publications and Presentations
Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/comparative-bleeding-risks-among-noac-users-nonvalvular Comparative Bleeding Risks Among NOAC Users for Nonvalvular Atrial Fibrillation Aged Under 65 years in the Sentinel System Publications and Presentations
Comparative Bleeding Risks Among NOAC Users for Nonvalvular Atrial Fibrillation Aged Under 65 years in the Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-active Outcome Monitoring Following Guselkumab Use: An Active Comparator Signal Identification Analysis Analyses
Outcome Monitoring Following Guselkumab Use: An Active Comparator Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/exposure-valsartan-products-containing-nitrosamine Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark Publications and Presentations
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-risankizumab-use-supplemental Outcome Monitoring Following Risankizumab Use: A Supplemental Signal Identification Analysis Analyses
Outcome Monitoring Following Risankizumab Use: A Supplemental Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-risankizumab-use-signal Outcome Monitoring Following Risankizumab Use: A Signal Identification Analysis Analyses
Outcome Monitoring Following Risankizumab Use: A Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/scalable-incident-detection-natural-language-processing-and Scalable Incident Detection Via Natural Language Processing and Probabilistic Language Models Publications and Presentations
Scalable Incident Detection Via Natural Language Processing and Probabilistic Language Models
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/provigil-modafinil-and-nuvigil-armodafinil-0 Provigil (Modafinil) and Nuvigil (Armodafinil) & Congenital Cardiac and Non-Cardiac Malformations Studies
Provigil (Modafinil) and Nuvigil (Armodafinil) & Congenital Cardiac and Non-Cardiac Malformations
Studies
https://www.sentinelinitiative.org/studies/drugs/women-heart-failure Women with Heart Failure & Pregnancy Studies
Women with Heart Failure & Pregnancy
Studies
https://www.sentinelinitiative.org/news-events/publications-presentations/pediatric-utilization-new-molecular-entities-nmes-summary-0 Pediatric Utilization of New Molecular Entities (NMEs): A Summary of Early Post-marketing Uptake in the Sentinel Distributed Database Publications and Presentations
Pediatric Utilization of New Molecular Entities (NMEs): A Summary of Early Post-marketing Uptake in the Sentinel Distributed Database
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/analyzing-missingness-patterns-real-world-data-using-smdi Analyzing Missingness Patterns in Real-World Data Using the SMDI Toolkit: Application to a Linked EHR-Claims Pharmacoepidemiology Study Publications and Presentations
Analyzing Missingness Patterns in Real-World Data Using the SMDI Toolkit: Application to a Linked EHR-Claims Pharmacoepidemiology Study
Publications and Presentations
https://www.sentinelinitiative.org/news-events/fda-advisory-committee-meetings/meeting-endocrinologic-and-metabolic-drugs-advisory-1 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee: Sotagliflozin and Diabetic Ketoacidosis (October 31, 2024) Regulatory Impact
Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee: Sotagliflozin and Diabetic Ketoacidosis (October 31, 2024)
Regulatory Impact
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-self-controlled Outcome Monitoring Following Guselkumab Use: A Self-Controlled Risk Interval Signal Identification Analysis Analyses
Outcome Monitoring Following Guselkumab Use: A Self-Controlled Risk Interval Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-patients-healthcare-encounters-involving-0 Characteristics of Patients with Healthcare Encounters Involving Disorders or Poisoning Related to Cannabis: A Descriptive Analysis Analyses
Characteristics of Patients with Healthcare Encounters Involving Disorders or Poisoning Related to Cannabis: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-healthcare-encounters-involving-disorders-or Trends in Healthcare Encounters Involving Disorders or Poisoning Related to Cannabis, Stratified by the Legality Status of Cannabis by State and Territory: A Descriptive Analysis Analyses
Trends in Healthcare Encounters Involving Disorders or Poisoning Related to Cannabis, Stratified by the Legality Status of Cannabis by State and Territory: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/covid-19-emergency-use-authorization-eua-drugs COVID-19 Emergency Use Authorization (EUA) Drugs & Utilization, Anaphylaxis, and Hospitalization Studies
COVID-19 Emergency Use Authorization (EUA) Drugs & Utilization, Anaphylaxis, and Hospitalization
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-valsartan-descriptive-analysis Utilization of Valsartan: A Descriptive Analysis Analyses
Utilization of Valsartan: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-hormonal-contraceptives-following-live-birth-or Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Descriptive Analysis Analyses
Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/clinical-characteristics-incident-users-glucagon-peptide-1 Clinical Characteristics of Incident Users of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) in TriNetX: A Descriptive Analysis Analyses
Clinical Characteristics of Incident Users of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) in TriNetX: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/demographic-characteristics-incident-users-selected-non Demographic Characteristics of Incident Users of Selected Non-Insulin Antidiabetics in TriNetX: A Descriptive Analysis Analyses
Demographic Characteristics of Incident Users of Selected Non-Insulin Antidiabetics in TriNetX: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-selected-non-insulin-antidiabetics-trinetx Utilization of Selected Non-Insulin Antidiabetics in TriNetX: A Descriptive Analysis Analyses
Utilization of Selected Non-Insulin Antidiabetics in TriNetX: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/software-packages-toolkits/centers-medicare-and-medicaid-services-cms-medicaid The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format Methods, Data, & Tools
The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/methods/subset-calibration-methods Subset Calibration Methods Methods, Data, & Tools
Subset Calibration Methods
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/publications-presentations/assessing-treatment-effects-observational-data-missing Assessing Treatment Effects in Observational Data with Missing Confounders: A Comparative Study of Practical Doubly-robust and Traditional Missing-data Methods Publications and Presentations
Assessing Treatment Effects in Observational Data with Missing Confounders: A Comparative Study of Practical Doubly-robust and Traditional Missing-data Methods
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/cautionary-note-plasmode-simulation-studies-setting-causal A Cautionary Note for Plasmode Simulation Studies in the Setting of Causal Inference Publications and Presentations
A Cautionary Note for Plasmode Simulation Studies in the Setting of Causal Inference
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/characteristics-and-medication-use-patterns-pregnancies Characteristics and Medication Use Patterns of Pregnancies With COVID-19 Ending in Live-Birth in the Sentinel System Publications and Presentations
Characteristics and Medication Use Patterns of Pregnancies With COVID-19 Ending in Live-Birth in the Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system Sentinel Routine Querying System Methods, Data, & Tools
Sentinel Routine Querying System
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system-reporting-tool Sentinel Routine Querying System Reporting Tool Methods, Data, & Tools
Sentinel Routine Querying System Reporting Tool
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/prescriptions-and-dispensings-central-nervous-system-cns Prescriptions and Dispensings of Central Nervous System (CNS) Stimulants: A Descriptive Analysis Analyses
Prescriptions and Dispensings of Central Nervous System (CNS) Stimulants: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/duration-follow-new-molecular-entities-approved-2022-first Duration of Follow Up for New Molecular Entities Approved in 2022: First Descriptive Analysis Analyses
Duration of Follow Up for New Molecular Entities Approved in 2022: First Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-confounding-covariates-trinetx-descriptive Characterization of Confounding Covariates in TriNetX: A Descriptive Analysis Analyses
Characterization of Confounding Covariates in TriNetX: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/advances-drug-safety-surveillance-infrastructure-us-fda-1 Advances in Drug Safety Surveillance Infrastructure in the US FDA Sentinel Publications and Presentations
Advances in Drug Safety Surveillance Infrastructure in the US FDA Sentinel
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/cannabis-related-healthcare-encounters-among-us-commercially Cannabis-Related Healthcare Encounters Among U.S. Commercially Insured Adults Publications and Presentations
Cannabis-Related Healthcare Encounters Among U.S. Commercially Insured Adults
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-non-arteritic-anterior-ischemic-optic-neuropathy-naion Risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Following Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Use in Patients with Type 2 Diabetes Mellitus Analyses
Risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Following Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Use in Patients with Type 2 Diabetes Mellitus
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-single-dose-doxycycline-lyme-disease-prophylaxis-1 Trends in Single-Dose Doxycycline for Lyme Disease Prophylaxis in the United States: A Third Descriptive Analysis Analyses
Trends in Single-Dose Doxycycline for Lyme Disease Prophylaxis in the United States: A Third Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-mothers-mother-infant-linkage-table-0 Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: An Updated Descriptive Analysis Analyses
Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: An Updated Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/core-concepts-pharmacoepidemiology-multi-database Core Concepts in Pharmacoepidemiology: Multi-Database Distributed Data Networks Publications and Presentations
Core Concepts in Pharmacoepidemiology: Multi-Database Distributed Data Networks
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/cataracts-glaucoma-ocular-hypertension-diminished-visual Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis Analyses
Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/dipeptidyl-peptidase-4-dpp-4-inhibitors Dipeptidyl Peptidase-4 (DPP-4) Inhibitors & Inflammatory Bowel Disease Studies
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors & Inflammatory Bowel Disease
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-patterns-diabetes-mellitus-and-anti-obesity Utilization Patterns of Diabetes Mellitus and Anti-Obesity Drugs: A Descriptive Analysis Analyses
Utilization Patterns of Diabetes Mellitus and Anti-Obesity Drugs: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-inflammatory-bowel-disease-following-dipeptidyl Incidence of Inflammatory Bowel Disease Following Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Use in Patients with Type 2 Diabetes Mellitus: An Inverse Probability of Treatment Weighting Analysis Analyses
Incidence of Inflammatory Bowel Disease Following Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Use in Patients with Type 2 Diabetes Mellitus: An Inverse Probability of Treatment Weighting Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/gilenya-fingolimod-hydrochloride Gilenya (Fingolimod hydrochloride) & Cardiac Congenital Malformations, Urinary Congenital Malformations, Other Non-Cardiac and Non-Urinary Congenital Malformations, and All Congenital Malformations Studies
Gilenya (Fingolimod hydrochloride) & Cardiac Congenital Malformations, Urinary Congenital Malformations, Other Non-Cardiac and Non-Urinary Congenital Malformations, and All Congenital Malformations
Studies
https://www.sentinelinitiative.org/studies/drugs/valsartan-angiotensin-receptor-blockers Valsartan and Non-Valsartan Angiotensin Receptor Blockers & Nitrosamine Impurity and Switching Patterns Studies
Valsartan and Non-Valsartan Angiotensin Receptor Blockers & Nitrosamine Impurity and Switching Patterns
Studies
https://www.sentinelinitiative.org/studies/drugs/covid-19-patients-0 COVID-19 Patients & Coagulopathy and Availability of Laboratory Values Studies
COVID-19 Patients & Coagulopathy and Availability of Laboratory Values
Studies
https://www.sentinelinitiative.org/studies/drugs/drug-device-or-biologic-device-combinations-utilization Drug-Device or Biologic-Device Combinations & Utilization Studies
Drug-Device or Biologic-Device Combinations & Utilization
Studies
https://www.sentinelinitiative.org/studies/drugs/non-insulin-antidiabetic-agents Non-Insulin Antidiabetic Agents & Utilization Studies
Non-Insulin Antidiabetic Agents & Utilization
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-patients-healthcare-encounters-involving-1 Characteristics of Patients with Healthcare Encounters Involving Disorders or Poisoning Related to Cannabis: An Updated Descriptive Analysis Analyses
Characteristics of Patients with Healthcare Encounters Involving Disorders or Poisoning Related to Cannabis: An Updated Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/trends-healthcare-encounters-involving-disorders-or-0 Trends in Healthcare Encounters Involving Disorders or Poisoning Related to Cannabis, Stratified by the Legality Status of Cannabis by State and Territory: An Updated Descriptive Analysis Analyses
Trends in Healthcare Encounters Involving Disorders or Poisoning Related to Cannabis, Stratified by the Legality Status of Cannabis by State and Territory: An Updated Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/liposomal-doxorubicin Liposomal Doxorubicin & Generic Drug Therapeutic Equivalence Studies
Liposomal Doxorubicin & Generic Drug Therapeutic Equivalence
Studies
https://www.sentinelinitiative.org/studies/drugs/prograf-tacrolimus Prograf (Tacrolimus) & Generic to Brand Switching Studies
Prograf (Tacrolimus) & Generic to Brand Switching
Studies
https://www.sentinelinitiative.org/studies/drugs/lipiodol-ethiodized-oil Lipiodol (Ethiodized Oil) & Infant Thyroid Dysfunction Studies
Lipiodol (Ethiodized Oil) & Infant Thyroid Dysfunction
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-patients-allogeneic-hematopoietic-stem-cell Characterization of Patients with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) and Thrombotic Microangiopathy (TMA) Associated with HSCT (HSCT-TMA) in TriNetX: A Descriptive Analysis Analyses
Characterization of Patients with Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) and Thrombotic Microangiopathy (TMA) Associated with HSCT (HSCT-TMA) in TriNetX: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/products-development-pregnancy-safety-study-framework Products for the Development of the Pregnancy Safety Study Framework & Use in Pregnancy Studies
Products for the Development of the Pregnancy Safety Study Framework & Use in Pregnancy
Studies
https://www.sentinelinitiative.org/studies/drugs/beta-blockers Beta Blockers & Hypoglycemia Studies
Beta Blockers & Hypoglycemia
Studies
https://www.sentinelinitiative.org/news-events/fda-safety-communications-labeling-changes/fda-labeling-change-additional-language FDA Labeling Change: Additional Language to Mitigate the Risk of Hypoglycemia Associated with Beta Blockers in Children Regulatory Impact
FDA Labeling Change: Additional Language to Mitigate the Risk of Hypoglycemia Associated with Beta Blockers in Children
Regulatory Impact
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-and-rates-diabetic-ketoacidosis-dka-among Characteristics and Rates of Diabetic Ketoacidosis (DKA) Among Users of Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors, Sitagliptin, or Short/Rapid-Acting Insulin: A Descriptive Analysis Analyses
Characteristics and Rates of Diabetic Ketoacidosis (DKA) Among Users of Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors, Sitagliptin, or Short/Rapid-Acting Insulin: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-and-rates-diabetic-ketoacidosis-dka-chronic Characteristics and Rates of Diabetic Ketoacidosis (DKA) by Chronic Kidney Disease (CKD) Stage Among Patients with Short/Rapid-Acting Insulin Use and Type 1 Diabetes Mellitus (T1DM): A Descriptive Analysis Assessments
Characteristics and Rates of Diabetic Ketoacidosis (DKA) by Chronic Kidney Disease (CKD) Stage Among Patients with Short/Rapid-Acting Insulin Use and Type 1 Diabetes Mellitus (T1DM): A Descriptive Analysis
Assessments
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/crenessity-crinecerfont Assessment of ARIA Sufficiency: Crenessity (crinecerfont) Sufficiency Assessments
Assessment of ARIA Sufficiency: Crenessity (crinecerfont)
Sufficiency Assessments
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/imaavy-nipocalimab-aahu Assessment of ARIA Sufficiency: Imaavy (nipocalimab-aahu) Sufficiency Assessments
Assessment of ARIA Sufficiency: Imaavy (nipocalimab-aahu)
Sufficiency Assessments
https://www.sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/romvimza-vimseltinib Assessment of ARIA Sufficiency: Romvimza (vimseltinib) Sufficiency Assessments
Assessment of ARIA Sufficiency: Romvimza (vimseltinib)
Sufficiency Assessments
https://www.sentinelinitiative.org/studies/drugs/mother-infant-linkage-table Mother-Infant Linkage Table & Characterization Studies
Mother-Infant Linkage Table & Characterization
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/incidence-hospitalized-tachyarrhythmia-patients-type-2 Incidence of Hospitalized Tachyarrhythmia in Patients with Type 2 Diabetes Mellitus Using Tirzepatide or Other Long-Acting Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: A Descriptive Analysis Analyses
Incidence of Hospitalized Tachyarrhythmia in Patients with Type 2 Diabetes Mellitus Using Tirzepatide or Other Long-Acting Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/mayzent-siponimod Mayzent (Siponimod) & Use in Pregnancy Studies
Mayzent (Siponimod) & Use in Pregnancy
Studies
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/diabetic-ketoacidosis-algorithm-defined-rates-diabetic Diabetic Ketoacidosis Algorithm Defined in "Rates of Diabetic Ketoacidosis (DKA) by Chronic Kidney Disease (CKD) Stage Among Patients with Type 1 Diabetes Mellitus (T1DM): A Propensity Score Matched Analysis" Methods, Data, & Tools
Diabetic Ketoacidosis Algorithm Defined in "Rates of Diabetic Ketoacidosis (DKA) by Chronic Kidney Disease (CKD) Stage Among Patients with Type 1 Diabetes Mellitus (T1DM): A Propensity Score Matched Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/rates-diabetic-ketoacidosis-dka-chronic-kidney-disease-ckd Rates of Diabetic Ketoacidosis (DKA) by Chronic Kidney Disease (CKD) Stage Among Patients with Type 1 Diabetes Mellitus (T1DM): A Propensity Score Matched Analysis Analyses
Rates of Diabetic Ketoacidosis (DKA) by Chronic Kidney Disease (CKD) Stage Among Patients with Type 1 Diabetes Mellitus (T1DM): A Propensity Score Matched Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/automated-extraction-mortality-information-publicly Automated Extraction of Mortality Information from Publicly Available Sources Using Language Models Publications and Presentations
Automated Extraction of Mortality Information from Publicly Available Sources Using Language Models
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-dosage-attention-deficithyperactivity Characterization of Dosage of Attention-Deficit/Hyperactivity Disorder (ADHD) Stimulant Medications: A Descriptive Analysis Analyses
Characterization of Dosage of Attention-Deficit/Hyperactivity Disorder (ADHD) Stimulant Medications: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-use-attention-deficithyperactivity-disorder Characterization of Use of Attention-Deficit/Hyperactivity Disorder (ADHD) Medications or Opioid Analgesics: A Descriptive Analysis Analyses
Characterization of Use of Attention-Deficit/Hyperactivity Disorder (ADHD) Medications or Opioid Analgesics: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-confounding-covariates-sentinel-distributed Characterization of Confounding Covariates in the Sentinel Distributed Database (SDD): A Descriptive Analysis Analyses
Characterization of Confounding Covariates in the Sentinel Distributed Database (SDD): A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-biktarvy-odefsey-symtuza-and-genvoya-descriptive Utilization of Biktarvy, Odefsey, Symtuza, and Genvoya: A Descriptive Analysis Analyses
Utilization of Biktarvy, Odefsey, Symtuza, and Genvoya: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2025-ispe-annual-meeting 2025 ISPE Annual Meeting Sentinel Initiative Events
2025 ISPE Annual Meeting
Sentinel Initiative Events
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following Outcome Monitoring Following Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) Use: A Self-Controlled Risk Interval Signal Identification Analysis Analyses
Outcome Monitoring Following Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) Use: A Self-Controlled Risk Interval Signal Identification Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/proportion-incident-syndrome-inappropriate-antidiuretic Proportion of Incident Syndrome of Inappropriate Antidiuretic Hormone Secretion Cases with Evidence of Pulmonary Opportunistic Infections Among New Users of BIC/TC/TAF: A Descriptive Analysis Analyses
Proportion of Incident Syndrome of Inappropriate Antidiuretic Hormone Secretion Cases with Evidence of Pulmonary Opportunistic Infections Among New Users of BIC/TC/TAF: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/prevalence-major-congenital-malformations-among-insured Prevalence of Major Congenital Malformations Among the Insured Population in the United States Using Seven Algorithms Publications and Presentations
Prevalence of Major Congenital Malformations Among the Insured Population in the United States Using Seven Algorithms
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/self-reported-use-non-fda-approved-cannabinoid-products Self-Reported Use of Non-FDA Approved Cannabinoid Products Among Hospitalized Patients in a Large U.S. Hospital Network Publications and Presentations
Self-Reported Use of Non-FDA Approved Cannabinoid Products Among Hospitalized Patients in a Large U.S. Hospital Network
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/insights-harmonizing-laboratory-results-data-sentinel-system Insights on Harmonizing Laboratory Results Data in the Sentinel System Publications and Presentations
Insights on Harmonizing Laboratory Results Data in the Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/electronic-health-record-ehr-enhanced-signal-detection-using Electronic Health Record (EHR) Enhanced Signal Detection Using Tree-Based Scan Statistic Methods Publications and Presentations
Electronic Health Record (EHR) Enhanced Signal Detection Using Tree-Based Scan Statistic Methods
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/risk-diabetic-ketoacidosis-across-stages-chronic-kidney Risk of Diabetic Ketoacidosis Across Stages of Chronic Kidney Disease in Patients with Type 1 Diabetes in the U.S. Food and Drug Administration’s Sentinel System Publications and Presentations
Risk of Diabetic Ketoacidosis Across Stages of Chronic Kidney Disease in Patients with Type 1 Diabetes in the U.S. Food and Drug Administration’s Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/risk-incident-inflammatory-bowel-disease-new-users-0 Risk of Incident Inflammatory Bowel Disease in New Users of Dipeptidyl Peptidase 4 Inhibitors, Sodium Glucose Cotransporter 2 Inhibitors, or Sulfonylurea in the U.S. Food and Drug Administration’s Sentinel System Publications and Presentations
Risk of Incident Inflammatory Bowel Disease in New Users of Dipeptidyl Peptidase 4 Inhibitors, Sodium Glucose Cotransporter 2 Inhibitors, or Sulfonylurea in the U.S. Food and Drug Administration’s Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/addressing-threat-confounding-pharmacoepidemiology Addressing the Threat of Confounding in Pharmacoepidemiology with Innovative Methods: Lessons from the FDA Sentinel Innovation Center Publications and Presentations
Addressing the Threat of Confounding in Pharmacoepidemiology with Innovative Methods: Lessons from the FDA Sentinel Innovation Center
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/strengthening-inferential-studies-us-fda-sentinel-initiative Strengthening Inferential Studies in the U.S. FDA Sentinel Initiative: Results from a Methodological Demonstration Project Publications and Presentations
Strengthening Inferential Studies in the U.S. FDA Sentinel Initiative: Results from a Methodological Demonstration Project
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/assessment-utilization-patterns-new-molecular-entities Assessment of Utilization Patterns of New Molecular Entities Approved in 2022 using the Sentinel Distributed Database Publications and Presentations
Assessment of Utilization Patterns of New Molecular Entities Approved in 2022 using the Sentinel Distributed Database
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/attention-deficithyperactivity-disorder-medication Attention-Deficit/Hyperactivity Disorder Medication Utilization Among U.S. Adults Ages 18-64 Years with Commercial Insurance or Medicare: Implications for Design of Inferential Safety Studies Publications and Presentations
Attention-Deficit/Hyperactivity Disorder Medication Utilization Among U.S. Adults Ages 18-64 Years with Commercial Insurance or Medicare: Implications for Design of Inferential Safety Studies
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/characterization-confounding-covariate-data-capture-us-food Characterization of Confounding Covariate Data Capture in the U.S. Food and Drug Administration’s Sentinel Distributed Database Publications and Presentations
Characterization of Confounding Covariate Data Capture in the U.S. Food and Drug Administration’s Sentinel Distributed Database
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/developing-computable-phenotypes-medical-product-safety Developing Computable Phenotypes for Medical Product Safety Surveillance: Innovative Methods and Data Sources Publications and Presentations
Developing Computable Phenotypes for Medical Product Safety Surveillance: Innovative Methods and Data Sources
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/utilization-type-2-diabetes-mellitus-products-sentinel Utilization of Type 2 Diabetes Mellitus Products in the Sentinel Distributed Database, 2008-2024 Publications and Presentations
Utilization of Type 2 Diabetes Mellitus Products in the Sentinel Distributed Database, 2008-2024
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/use-glucagon-peptide-1-receptor-agonists-us-food-and-drug Use of Glucagon-Like Peptide-1 Receptor Agonists in the U.S. Food and Drug Administration’s Sentinel System Publications and Presentations
Use of Glucagon-Like Peptide-1 Receptor Agonists in the U.S. Food and Drug Administration’s Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/pregnancy-algorithms Pregnancy Algorithms & Characterization Studies
Pregnancy Algorithms & Characterization
Studies
https://www.sentinelinitiative.org/studies/drugs/skyrizi-risankizumab-rzaa Skyrizi (Risankizumab-Rzaa) & Signal Identification Studies
Skyrizi (Risankizumab-Rzaa) & Signal Identification
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/improving-identification-pregnancies-claims-data-descriptive Improving the Identification of Pregnancies in Claims Data: A Descriptive Analysis Analyses
Improving the Identification of Pregnancies in Claims Data: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/publications-presentations/cannabis-related-healthcare-encounters-among-commercially Cannabis-Related Healthcare Encounters Among Commercially Insured Adults Aged 18-64 years Contributing Data to the US Food and Drug Administration’s Sentinel, 2017-2022 Publications and Presentations
Cannabis-Related Healthcare Encounters Among Commercially Insured Adults Aged 18-64 years Contributing Data to the US Food and Drug Administration’s Sentinel, 2017-2022
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/characterization-mothers-sentinel-distributed-database Characterization of Mothers in the Sentinel Distributed Database Mother-Infant Linkage Table Publications and Presentations
Characterization of Mothers in the Sentinel Distributed Database Mother-Infant Linkage Table
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/prevalence-key-confounding-covariates-commercial-electronic Prevalence of Key Confounding Covariates in a Commercial Electronic Health Records Platform Publications and Presentations
Prevalence of Key Confounding Covariates in a Commercial Electronic Health Records Platform
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/single-dose-doxycycline-lyme-disease-prophylaxis-children Single-Dose Doxycycline for Lyme Disease Prophylaxis in Children in a Large United States Healthcare Database, 2016-2020 Publications and Presentations
Single-Dose Doxycycline for Lyme Disease Prophylaxis in Children in a Large United States Healthcare Database, 2016-2020
Publications and Presentations
https://www.sentinelinitiative.org/news-events/publications-presentations/utilization-hormonal-contraceptives-during-postpartum-period Utilization of Hormonal Contraceptives During the Postpartum Period in the FDA Sentinel System Publications and Presentations
Utilization of Hormonal Contraceptives During the Postpartum Period in the FDA Sentinel System
Publications and Presentations
https://www.sentinelinitiative.org/methods-data-tools/methods/use-case-2-uc2-aim-4-identifying-use-cannabis-derived-products-cdp-free Use Case 2 (UC2) Aim 4: Identifying Use of Cannabis-Derived Products (CDP) from Free-Text Notes Methods, Data, & Tools
Use Case 2 (UC2) Aim 4: Identifying Use of Cannabis-Derived Products (CDP) from Free-Text Notes
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/methods/use-case-2-uc2-aim-3-real-time-validation-code-based-algorithms Use Case 2 (UC2) Aim 3: Real-Time Validation of Code-Based Algorithms Methods, Data, & Tools
Use Case 2 (UC2) Aim 3: Real-Time Validation of Code-Based Algorithms
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/methods/use-case-2-uc2-aim-1-rapid-confounder-balance-evaluation-factors Use Case 2 (UC2) Aim 1: Rapid Confounder Balance Evaluation of Factors Unmeasured in Sentinel Claims Data Methods, Data, & Tools
Use Case 2 (UC2) Aim 1: Rapid Confounder Balance Evaluation of Factors Unmeasured in Sentinel Claims Data
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/methods/chart-review-major-congenital-malformations Chart Review of Major Congenital Malformations Methods, Data, & Tools
Chart Review of Major Congenital Malformations
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/drug-utilization-patients-polyarticular-juvenile-idiopathic Drug Utilization in Patients with Polyarticular Juvenile Idiopathic Arthritis (pJIA): A Descriptive Analysis Analyses
Drug Utilization in Patients with Polyarticular Juvenile Idiopathic Arthritis (pJIA): A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/methods/use-case-2-uc2-aim-5-plasmode-simulation-based-quantitative-bias Use Case 2 (UC2) Aim 5: Plasmode Simulation Based Quantitative Bias Analysis (QBA) for Unmeasured Confounding Methods, Data, & Tools
Use Case 2 (UC2) Aim 5: Plasmode Simulation Based Quantitative Bias Analysis (QBA) for Unmeasured Confounding
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/publications-presentations/electronic-health-record-ehr-enhanced-signal-detection-0 Electronic Health Record (EHR) Enhanced Signal Detection Using Tree-Based Scan Statistic Methods Publications and Presentations
Electronic Health Record (EHR) Enhanced Signal Detection Using Tree-Based Scan Statistic Methods
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/biktarvy-bictegraviremtricitabinetenofovir-alafenamide Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) & Signal Identification Studies
Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) & Signal Identification
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-syphilis-testing-and-treatment-infants Characterization of Syphilis Testing and Treatment in Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis Analyses
Characterization of Syphilis Testing and Treatment in Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-syphilis-testing-and-treatment-pregnant Characterization of Syphilis Testing and Treatment in Pregnant Women: A Descriptive Analysis Analyses
Characterization of Syphilis Testing and Treatment in Pregnant Women: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/syphilis-diagnosis-algorithm-defined-characterization Syphilis Diagnosis Algorithm Defined in "Characterization of Syphilis Testing and Treatment in Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis" Methods, Data, & Tools
Syphilis Diagnosis Algorithm Defined in "Characterization of Syphilis Testing and Treatment in Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/syphilis-diagnosis-algorithm-defined-characterization-0 Syphilis Diagnosis Algorithm Defined in "Characterization of Syphilis Testing and Treatment in Pregnant Women: A Descriptive Analysis" Methods, Data, & Tools
Syphilis Diagnosis Algorithm Defined in "Characterization of Syphilis Testing and Treatment in Pregnant Women: A Descriptive Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/syphilis-testing-algorithm-defined-characterization Syphilis Testing Algorithm Defined in "Characterization of Syphilis Testing and Treatment in Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis" Methods, Data, & Tools
Syphilis Testing Algorithm Defined in "Characterization of Syphilis Testing and Treatment in Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/syphilis-testing-algorithm-defined-characterization-0 Syphilis Testing Algorithm Defined in "Characterization of Syphilis Testing and Treatment in Pregnant Women: A Descriptive Analysis" Methods, Data, & Tools
Syphilis Testing Algorithm Defined in "Characterization of Syphilis Testing and Treatment in Pregnant Women: A Descriptive Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/syphilis-treatment-infants-algorithm-defined Syphilis Treatment for Infants Algorithm Defined in "Characterization of Syphilis Testing and Treatment in Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis" Methods, Data, & Tools
Syphilis Treatment for Infants Algorithm Defined in "Characterization of Syphilis Testing and Treatment in Infants in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/syphilis-treatment-pregnant-women-and-non-standard Syphilis Treatment for Pregnant Women and Non-Standard Syphilis Treatment Algorithm Defined in "Characterization of Syphilis Testing and Treatment in Pregnant Women: A Descriptive Analysis" Methods, Data, & Tools
Syphilis Treatment for Pregnant Women and Non-Standard Syphilis Treatment Algorithm Defined in "Characterization of Syphilis Testing and Treatment in Pregnant Women: A Descriptive Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/publications-presentations/capturing-pediatric-health-and-medication-use-us-national Capturing Pediatric Health and Medication Use in a US National Health Data Network Publications and Presentations
Capturing Pediatric Health and Medication Use in a US National Health Data Network
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-hormonal-contraceptives-following-live-birth-0 Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Second Descriptive Analysis Assessments
Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Second Descriptive Analysis
Assessments
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/cataracts-algorithm-defined-cataracts-glaucoma-ocular Cataracts Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis" Methods, Data, & Tools
Cataracts Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/diminished-visual-acuity-algorithm-defined-cataracts Diminished Visual Acuity Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis" Methods, Data, & Tools
Diminished Visual Acuity Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/glaucoma-algorithm-defined-cataracts-glaucoma-ocular Glaucoma Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis" Methods, Data, & Tools
Glaucoma Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/nasal-septal-perforation-algorithm-defined-cataracts Nasal Septal Perforation Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis" Methods, Data, & Tools
Nasal Septal Perforation Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/methods-data-tools/health-outcomes-interest/ocular-hypertension-algorithm-defined-cataracts Ocular Hypertension Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis" Methods, Data, & Tools
Ocular Hypertension Algorithm Defined in "Cataracts, Glaucoma, Ocular Hypertension, Diminished Visual Acuity, and Nasal Septal Perforation Following Sinuva and Propel (Mometasone Furoate Sinus Implants) Use: A Descriptive Analysis"
Methods, Data, & Tools
https://www.sentinelinitiative.org/studies/drugs/confounding-conditions Confounding Conditions & Characterization Studies
Confounding Conditions & Characterization
Studies
https://www.sentinelinitiative.org/methods-data-tools/methods/developing-prediction-model-estimate-magnitude-exposure Developing a Prediction Model to Estimate the Magnitude of Exposure Methods, Data, & Tools
Developing a Prediction Model to Estimate the Magnitude of Exposure
Methods, Data, & Tools
https://www.sentinelinitiative.org/news-events/publications-presentations/assessment-sentinel-system-2022-2024 An Assessment of the Sentinel System (2022 to 2024) Publications and Presentations
An Assessment of the Sentinel System (2022 to 2024)
Publications and Presentations
https://www.sentinelinitiative.org/studies/drugs/central-nervous-system-stimulants-0 Central Nervous System Stimulants & Utilization Studies
Central Nervous System Stimulants & Utilization
Studies
https://www.sentinelinitiative.org/studies/drugs/covid-19-1 COVID-19 & Severity Algorithm Studies
COVID-19 & Severity Algorithm
Studies
https://www.sentinelinitiative.org/studies/drugs/central-nervous-system-stimulants Central Nervous System Stimulants & Patient Characteristics and Utilization Studies
Central Nervous System Stimulants & Patient Characteristics and Utilization
Studies
https://www.sentinelinitiative.org/studies/drugs/valcyte-valganciclovir Valcyte (Valganciclovir) & Congenital Cytomegalovirus Studies
Valcyte (Valganciclovir) & Congenital Cytomegalovirus
Studies
https://www.sentinelinitiative.org/studies/drugs/gilenya-fingolimod Gilenya (Fingolimod) & Multiple Sclerosis Relapse Studies
Gilenya (Fingolimod) & Multiple Sclerosis Relapse
Studies
https://www.sentinelinitiative.org/studies/drugs/new-molecular-entities-nmes New Molecular Entities (NMEs) & Utilization Characterization Studies
New Molecular Entities (NMEs) & Utilization Characterization
Studies
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-most-frequent-diagnoses-procedures Characterization of Most Frequent Diagnoses, Procedures, Medications and Labs Associated with Use of Finerenone in TriNetX: A Descriptive Analysis Analyses
Characterization of Most Frequent Diagnoses, Procedures, Medications and Labs Associated with Use of Finerenone in TriNetX: A Descriptive Analysis
Analyses
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2025-17th-annual-public-workshop 2025 17th Annual Public Workshop Sentinel Initiative Events 11/06/2025
2025 17th Annual Public Workshop
Sentinel Initiative Events